Turion Labs
AION Labs is a venture studio dedicated to building and investing in startups that leverage AI to revolutionize drug discovery and development. It is a unique partnership formed by AstraZeneca, Merck, Pfizer, Teva, the Israel Biotech Fund, Amiti Ventures, and AWS. AION Labs combines deep pharmaceutical R&D expertise with cutting-edge AI to create de-risked, industry-aligned ventures. Through its …
Profile
Turion Labs is a Singapore-headquartered biotech innovation platform that provides shared laboratory infrastructure, contract research organization (CRO) services, and regulatory navigation to help early-stage life science and food-tech companies scale in Southeast Asia. Incorporated in June 2025, the company operates as a joint venture between South Korea’s S&S LAB and Indonesia’s Future Lestari.
The company maintains a headquarters in Singapore and a flagship facility at the BSD Biomedical Campus in Indonesia. It is currently active with an estimated staff of 1 to 10 employees. While no formal venture capital funding rounds have been disclosed, the company is backed by its founding partners and maintains strategic industry connections. Expansion plans include additional sites in Thailand, Malaysia, and the Philippines.
Sources#
- Turion Labs | Your Indonesia’s Market Landing Pad for Biotech Breakthroughs
- Turion Labs — Whiteford Research Biobase
- Turion Labs launches in Singapore — 2025-05-15
- Turion Labs launches in Singapore to accelerate biotech across Southeast Asia | PPTI News — 2025-05-08
- TURION LABS PTE. LTD. (G) - Letting and operating of self-owned or leased real estate property (except food courts, hawker centres, coffee shops and canteens) - Singapore Company
- Turion Labs
- Turion Labs Revenue, Funding & Valuation
- Turion Labs Launches in Singapore to Expand Biotech Infrastructure Across Southeast Asia — 2025-05-07
- Industry
- Industrial chemistry
- Topics
- Synthetic biology platforms & biomanufacturing
- Role
- Research / RTO — “…ry infrastructure, contract research organization (CRO) services, and regulatory navigation to help early-stag…”
Bio-solutions it supplies 0
Not yet cited as a supplier in a graded solution.
What they offer
This company does not publish its products or services — we find out through an introduction.
News & status 6
- 2025-06 Latest status: The company was incorporated in Singapore on June 3, 2025, following its public launch in May 2025. ↗ ↗ ↗
- 2025-05-15 Turion Labs launches in SingaporeTurion Labs is a Singapore-based, first-of-its-kind, full-stack biotech innovation platform in Southeast Asia that provides shared lab infrastructure, CRO services, and regulatory support to help food tech startups reduce CAPEX and accelerate pilot testing and …
- 2025-05-07 Turion Labs launches biotech platform in Southeast AsiaTurion Labs has launched Southeast Asia’s first full-stack biotech innovation platform, aiming to accelerate start-ups with shared lab infrastructure, CRO services, and regulatory support, backed by S&S LAB and Future Lestari, with plans to expand across the …
- 2025-05-08 Turion Labs launches in Singapore to accelerate biotech across Southeast Asia | PPTI NewsTurion Labs is launching a Singapore-based, cross-border biotech platform backed by Korea’s S&S LAB and Indonesia’s Future Lestari to accelerate Southeast Asia’s biotech through a full-stack ecosystem of modular labs, CRO/regulatory support, and pilot R&D, …
- 2025-08-28 We’re excited to kick off a strategic collaboration with Turion Labs, a rising biotech launchpad in South-East Asia. Earlier this year, we signed a Memorandum of Understanding that marks the beginning of …Turion Labs is portrayed as a rising Southeast Asian biotech launchpad poised to accelerate deeptech breakthroughs in biotech and life sciences through strategic collaboration with partners like the described organization.
- 2025-05-07 Turion Labs launches in Singapore to power Southeast Asia’s biotech breakthroughs - Asia Food JournalTurion Labs is launching as Southeast Asia’s first full-stack biotech innovation platform, backed by S&S LAB Korea and Indonesia’s Future Lestari, with a flagship facility at Sinarmas Land Biomedical Hub in BSD City, Indonesia, and Singapore as its base. It …
- 2025-08-25 Thank you, National University of Singapore - NUS Yong Loo Lin School of Medicine / NUS Medicine Digital Advanced Technology Accelerator for tapping into our director's Dr Alvin Ng, and his insights …Turion Labs is actively engaging with academic accelerators (NUS Medicine Digital Advanced Technology Accelerator) to refine its startups’ pitches, leveraging expert coaching from Dr. Alvin Ng on storytelling and audience engagement ahead of Demo Day.
Network: owners, partners, peers
Ownership & investors 3
| parent | Joint venture / backed by S&S LAB |
| investor | S&S LAB |
| investor | Future Lestari |
Partners & deals 1
| joint venture | Southeast Asia …h companies scale in Southeast Asia. Incorporated in June 2025, the company operates as a joint venture between South Korea’s S&S LAB and Indonesia’s Future Lestari.
The company maintains a he… |
Similar companies
Pharmaron · WuXi Biologics · BiBo Biopharma Engineering Co.,Ltd. · Aragen Life Sciences · WuXi XDC · TCG Lifesciences Pvt Ltd. · Sinopep Jiangsu Inc. · ESCO ASTER PTE LTD
Identity & contacts
Contacts, people and legal identity are available to members.
Sign in as a member